Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

DIAZYME LABORATORIES

Diazyme develops diagnostic reagents using its proprietary enzyme technologies that can be used on most automated che... read more Featured Products: More products

Download Mobile App





Diazyme Presents Clinical Chemistry Assays for Cancer Biomarkers and Diabetes at MEDICA 2026

By LabMedica International staff writers
Posted on 19 Nov 2026

Diazyme Laboratories (Poway, CA, USA) is showcasing its clinical chemistry assay portfolio at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. More...

Its exhibit at Hall 3, Stand D15-1 covers gastrointestinal health markers, free light chains, total bile acids, and vitamin D testing. The display also features the Human Kappa Free Light Chain Assay, α-Fetoprotein (AFP) Assay, and Direct HbA1c (Enzymatic, On-Board Lysis) Assay, highlighting applications in cancer-related biomarker testing and diabetes monitoring.

Among the featured products, Diazyme’s Human Kappa Free Light Chain Assay uses latex-enhanced immunoturbidimetry to quantify kappa free light chains in serum. Combined with lambda free light chain measurements and other clinical findings, these results aid in diagnosing and monitoring multiple myeloma. Precision testing conducted according to CLSI EP5-A guidelines demonstrated within-run precision of 1.1%–7.9% and total precision of 1.7%–11.7%.

For cancer-related biomarker testing, Diazyme is also presenting its α-Fetoprotein (AFP) Assay, a dual liquid-stable reagent system that measures AFP to support evaluation of certain cancers, including hepatocellular carcinoma. Requiring 7 µL of serum or plasma, the assay delivers results in less than 10 minutes. Comparisons with commercial assays demonstrated an R² value of 0.9793 and a slope of 0.999, while within-run precision was below 7.6%. 

Another featured product is the Direct HbA1c (Enzymatic, On-Board Lysis) Assay, designed for high-throughput glycated hemoglobin testing without offline sample pretreatment. The assay uses a patented single-channel enzymatic method that eliminates the need for a separate total hemoglobin measurement channel, helping improve laboratory turnaround time. It provides an analytical measurement range of 4.0%–12.0% HbA1c and is designed to minimize interference from hemoglobin variants and post-translational modifications. 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Led by Professor Sherry Chan Kit-wa (middle), the HKUMed research team provides the first large-scale Chinese population evidence to support reviewing Hong Kong’s long-term blood-monitoring requirements for clozapine use. (Photo courtesy of HKUMed)

Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.